| OTCHX | PMBPX | OTCHX / PMBPX | |
| Total Expense Ratio | 1.03 | 0.83 | 124% |
| Annual Report Gross Expense Ratio | 1.04 | 0.83 | 125% |
| Fund Existence | 21 years | 25 years | - |
| Gain YTD | -9.554 | -2.554 | 374% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 14.4B | 31.2B | 46% |
| Annual Yield % from dividends | 0.00 | 0.01 | - |
| Returns for 1 year | -11.77 | -4.50 | 261% |
| Returns for 3 years | 16.93 | 39.23 | 43% |
| Returns for 5 years | -8.81 | 20.39 | -43% |
| Returns for 10 years | 81.15 | 103.85 | 78% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FMAG | 34.68 | 0.05 | +0.15% |
| Fidelity Magellan ETF | |||
| GSST | 50.65 | 0.01 | +0.02% |
| Goldman Sachs Ultra Short Bond ETF | |||
| LFAO | 168.64 | N/A | N/A |
| LifeX 2055 Longevity Income ETF | |||
| RDTE | 30.99 | -0.11 | -0.35% |
| Roundhill Russell 2000 0DTECovCllStgyETF | |||
| GNOM | 47.20 | -0.44 | -0.93% |
| Global X Genomics & Biotechnology ETF | |||